Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next generation products Anil Narasimha, Ph.D. joins as Chief Commercial Officer CAMBRIDGE, Mass.–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform […]
Partnership Expands Access to Scalable, High-Quality Single Cell Analysis for Researchers SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier provider of Next-Generation Sequencing services for researchers worldwide, has been certified as part of Parse’s Certified Service Provider (CSP) program. […]
BOSTON–Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling. In the field […]
Acquisition to advance company’s cell culture portfolio with internationally recognized pioneer in organoid development Burlington, Massachusetts, United States of America — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement with the intention to acquire […]
First group of CSPs to offer MERSCOPE Platform Services and forthcoming MERFISH 2.0 Chemistry to global researchers CAMBRIDGE, Mass. ─ Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch of its Certified Service Provider (CSP) program. The CSP initiative aims to empower researchers […]
BOTHELL, Wash. — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Tony J. Hunt, Executive Chairman of Repligen Corporation (Nasdaq: RGEN) and a recognized leader in bioprocessing innovation, to its board of directors effective January 2, 2025. […]
bit.bio Raises $30 Million Led by M&G Investments to Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets. Jonathan Milner Appointed Interim CEO; Mark Kotter Assumes Vice Chairman Role as Company Expands Board with Distinguished Biotech Leaders. Cambridge, UK – bit.bio, the global leader in cell programming technology, today announced the successful […]
Shimadzu Corporation has signed an investment contract with U-Medico Inc, (head office: Osaka prefecture; hereinafter U-Medico), a contract research organization (CRO). In accordance with this investment, from December 2024, Shimadzu has collaboratively developed a gene therapy pharmaceuticals manufacturing platform aimed at pharmaceutical companies, contract development and manufacturing organizations (CDMO), and educational & research institutions, and […]
BOSTON — Dapu Biotechnology (DPBIO), an industry leader in droplet microfluidic technology, and Leveragen, Inc., a Boston-based biotech developing advanced genetic models for antibody discovery, have announced a strategic partnership to accelerate innovations in antibody drug development. The collaboration brings together DPBIO’s Cytospark™ droplet microfluidic single-B cell antibody discovery platform and Leveragen’s Singularity Sapiens Mouse, a next-generation […]
Series B Funding from Major Investors Deerfield Management, Foresite Capital and Medical Excellence Capital among others San Diego – Pleno, a clinical and multi-omics diagnostics company that is revolutionizing biological target detection, today announced the appointment of Dr. Vik Vaz M.D. as its new chief executive officer and to serve on its Board of Directors, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
